Literature DB >> 1983224

Transplantation of umbilical cord blood in Fanconi's anemia.

E Gluckman1, A Devergié, H Bourdeau-Esperou, D Thierry, R Traineau, A Auerbach, H E Broxmeyer.   

Abstract

It has been shown that human umbilical cord blood contains stem/progenitor cells comparable in number to that of adult bone marrow. We report here the first successful cases of transplantation of umbilical cord blood cells. The patients were suffering from Fanconi's anemia, complicated by severe aplastic anemia. During pregnancy, it was shown that the mother was carrying a sibling unaffected by the disease and with HLA identical to the patient. Cord blood was collected and frozen in liquid nitrogen at birth. After conditioning with low-dose cyclophosphamide (20 mg/kg) and thoraco-abdominal irradiation (5 grays), the patients received a cord blood transplant of thawed cells. Three patients have been transplanted without any immediate side-effect. One has not enough follow-up, but two patients are alive and well with complete donor hematologic reconstitution and no chronic graft versus host disease. Potential developments of this technique are an extension of applicability with regard to other diseases that might be transplanted and whether such transplants can be performed in adults. The relative immaturity of the lymphoid system at birth may be advantageous in decreasing the graft versus host reaction if these cells are used in a mismatched transplantation. Cord blood cell banks may be useful for transplants in patients lacking an HLA-identical donor.

Entities:  

Mesh:

Year:  1990        PMID: 1983224

Source DB:  PubMed          Journal:  Nouv Rev Fr Hematol


  10 in total

Review 1.  Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance.

Authors:  Young-June Kim; Hal E Broxmeyer
Journal:  Crit Rev Oncol Hematol       Date:  2010-08-19       Impact factor: 6.312

Review 2.  The hematopoietic system in the context of regenerative medicine.

Authors:  Christopher D Porada; Anthony J Atala; Graça Almeida-Porada
Journal:  Methods       Date:  2015-08-28       Impact factor: 3.608

3.  Pharmacological preconditioning for short-term ex vivo expansion of human umbilical cord blood hematopoietic stem cells by filgrastim.

Authors:  Nikolaos G Grigoriadis; Ioannis G Grigoriadis; Sofia Markoula; Minas Paschopoulos; Konstantinos Zikopoulos; Panagiotis Gr Apostolakopoulos; Ioannis S Vizirianakis; Ioannis Georgiou
Journal:  Am J Stem Cells       Date:  2016-05-15

Review 4.  Novel cord blood transplant therapies.

Authors:  Elizabeth J Shpall; Catherine M Bollard; Claudio Brunstein
Journal:  Biol Blood Marrow Transplant       Date:  2010-10-15       Impact factor: 5.742

Review 5.  Mesenchymal stem cells in ex vivo cord blood expansion.

Authors:  Simon N Robinson; Paul J Simmons; Hong Yang; Amin M Alousi; J Marcos de Lima; Elizabeth J Shpall
Journal:  Best Pract Res Clin Haematol       Date:  2011-02-23       Impact factor: 3.020

6.  A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells.

Authors:  Qing Ma; Haven R Garber; Sijie Lu; Hong He; Eran Tallis; Xiaoling Ding; Anna Sergeeva; Michael S Wood; Gianpietro Dotti; Barbara Salvado; Kathryn Ruisaard; Karen Clise-Dwyer; Lisa St John; Katayoun Rezvani; Gheath Alatrash; Elizabeth J Shpall; Jeffrey J Molldrem
Journal:  Cytotherapy       Date:  2016-06-02       Impact factor: 5.414

Review 7.  Enhancing the efficacy of engraftment of cord blood for hematopoietic cell transplantation.

Authors:  Hal E Broxmeyer
Journal:  Transfus Apher Sci       Date:  2016-05-12       Impact factor: 1.764

8.  Disrupted Signaling through the Fanconi Anemia Pathway Leads to Dysfunctional Hematopoietic Stem Cell Biology: Underlying Mechanisms and Potential Therapeutic Strategies.

Authors:  Anja Geiselhart; Amelie Lier; Dagmar Walter; Michael D Milsom
Journal:  Anemia       Date:  2012-05-23

Review 9.  Emerging CAR T Cell Strategies for the Treatment of AML.

Authors:  Paresh Vishwasrao; Gongbo Li; Justin C Boucher; D Lynne Smith; Susanta K Hui
Journal:  Cancers (Basel)       Date:  2022-02-27       Impact factor: 6.639

10.  Umbilical Cord Blood and Cord Tissue-Derived Cell Therapies for Neonatal Morbidities: Current Status and Future Challenges.

Authors:  Lindsay Zhou; Courtney McDonald; Tamara Yawno; Graham Jenkin; Suzanne Miller; Atul Malhotra
Journal:  Stem Cells Transl Med       Date:  2022-03-17       Impact factor: 6.940

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.